23 May 2013
Keywords: roche, new, diabetes, drug, goes, into, ph
Article | 16 June 2008
Swiss drug major Roche and French partner Ipsen are to progress their diabetes treatment taspoglutide into Phase III trials based ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 June 2008
© 2013 thepharmaletter.com